Top

Published in:

01-02-2021 | Bullous Pemphigoid | News item

Sofosbuvir increases risk of Stevens-Johnson syndrome

Published in: Reactions Weekly | Issue 1/2021

Excerpt

After conducting a safety review on the potential risk of sofosbuvir-associated severe cutaneous adverse reactions (SCAR), Health Canada has concluded that sofosbuvir-containing products may increase the risk of Stevens-Johnson syndrome (SJS). …

Health Canada. Summary Safety Review - Sofosbuvir-containing products - Health Canada. Internet Document : 27 Jan 2021. Available from: URL: https://hpr-rps.hres.ca/reg-content/summary-safety-review-detail.php?lang=en&linkID=SSR00256

Title: Sofosbuvir increases risk of Stevens-Johnson syndrome
Publication date: 01-02-2021
Publisher: Springer International Publishing
Keywords: Bullous Pemphigoid
Stevens-Johnson Syndrome
Ledipasvir
Erythema Exsudativum Multiforme
Erythema Exsudativum Multiforme
Published in: Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-90740-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Sofosbuvir increases risk of Stevens-Johnson syndrome

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Fluconazole/paracetamol

Bortezomib/daratumumab/dexamethasone

Mecobalamin

Multiple drugs

Ciclosporin/mycophenolate-mofetil

Azathioprine